Brent Egan to Cohort Studies
This is a "connection" page, showing publications Brent Egan has written about Cohort Studies.
Connection Strength
0.243
-
Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct; 58(4):579-87.
Score: 0.063
-
Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women. Ethn Dis. 2007; 17(4):617-23.
Score: 0.045
-
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006 Mar; 47(3):345-51.
Score: 0.042
-
The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9.
Score: 0.019
-
Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013 Oct; 15(10):717-22.
Score: 0.018
-
Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012 Oct 02; 60(14):1271-7.
Score: 0.017
-
Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):32-41.
Score: 0.014
-
Impact of nativity and race on "Stroke Belt" mortality. Hypertension. 1999 Jul; 34(1):57-62.
Score: 0.007
-
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):401-5.
Score: 0.007
-
Aldosterone in obesity. Endocr Res. 1998 Aug-Nov; 24(3-4):789-96.
Score: 0.006
-
Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer. J Clin Oncol. 1996 May; 14(5):1617-25.
Score: 0.005